Hangzhou (1)

Immunoglobulin Light Amyloidosis Cardiomyopathy (1)

Recruiting (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

current treatment of al-cm (1)

drug (1)

Other (1)

Observational (1)

immunoglobulin light amyloidosis cardiomyopathy

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Hangzhou, Zhejiang, China

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Jan 29, 2023